| abstract |
The present invention relates to an isolated antigenic Porphyromonas gingivalis polypeptide or nucleotide. The polypeptide is SEQ. ID. NO. 265 to SEQ. ID. NO. 528, SEQ. ID. NO. 531 and SEQ. ID. NO. An amino acid sequence selected from the group consisting of 532; Or SEQ. ID. NO. 265 to SEQ. ID. NO. 528, SEQ. ID. NO. 531 and SEQ. ID. NO. An amino acid sequence having at least 85%, preferably at least 95% homology with an amino acid sequence selected from the group consisting of 532; Or SEQ. ID. NO. 265 to SEQ. ID. NO. 528, SEQ. ID. NO. 531 and SEQ. ID. NO. At least 40 amino acids having a contiguous sequence of at least 40 amino acids having homology to a contiguous amino acid sequence selected from the group consisting of 532.n n n n Porphyromonas gingivalis, Periodontitis, Polypeptide, Nucleotide |